KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Jong-Seok Lee

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 8건 중 1-8 번을 표시중입니다.

1 Article A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors Byoung Chul Cho ; Ji-Youn Han ; Sang-We Kim ; et al 2022
2 Article Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study 김상위 ; Amy Roshak ; Byoung Chul Cho ; et al 2021
3 Article Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression Heejung Chae ; Jeong Eun Kim ; Wanlim Kim ; et al 2022
4 Article First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial 김상위 ; Adam Pluzanski ; Alain Vergnenegre ; et al 2021
5 Article First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial Sang-We Kim ; Adam Pluzanski ; Alain Vergnenegre ; et al 2022
6 Article Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea 김상위 ; Bong-Seog Kim ; Byoung Chul Cho ; et al 2020
7 Article Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05. 김상위 ; 민영주 ; Byoung-Yong Shim ; et al 2021
8 Article Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis 김상위 ; Byoung Chul Cho ; Cheol Hyeon Kim ; et al 2020

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.